Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy

Author： Leinwand Joshua   Zhao Binsheng   Guo Xiaotao   Krishnamoorthy Saravanan   Qi Jing   Graziano Joseph   Slavkovic Vesna   Bates Gleneara   Lewin Sharyn   Allendorf John   Chabot John   Schwartz Lawrence   Taub Robert  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.20, Iss.3, 2013-12, pp. : 553-559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic Indicators for Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma †

By Yan Tristan   Brun Erwin   Cerruto Carlos   Haveric Namik   Chang David   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 41-49

Springer Publishing Company

Access to resources Recommend Favorite

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

By Blackham Aaron  

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2720-2727

Springer Publishing Company

Access to resources Recommend Favorite

Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

By Baratti D.  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 463-472

Springer Publishing Company

Access to resources Recommend Favorite

Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma—A Prospective Study of 70 Consecutive Cases

By Yan Tristan   Edwards Gary   Alderman Robert   Marquardt Christina   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite

In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

By Baratti D.  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1713-1714

Springer Publishing Company

Access to resources Recommend Favorite